MedCity News March 17, 2022
Illumina Accelerator has invested in 68 companies so far, all of them startups developing genomics technologies. Seven startups comprise the latest cohort selected by the startup engine.
Gene sequencing giant Illumina, a provider of analysis used in diagnosing disease and developing new medicines, also operates an accelerator that supports genomics-focused startups. On Thursday, Illumina Accelerator unveiled its fourth funding cycle, which has invested in seven startups.
The accelerator has two, six-month funding cycles per year. Startups selected get access to seed investment, use of Illumina sequencing systems and reagents, business guidance, genomics expertise, and lab space that is adjacent to Illumina campuses in Cambridge, UK, or in the San Francisco area. In total, Illumina Accelerator says that to date, it...
Today's Sponsors
Today's Sponsor